{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:40:31Z","timestamp":1787164831178,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008169","name":"Minneapolis Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cct.2023.107184","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:54:56Z","timestamp":1681214096000},"page":"107184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States"],"prefix":"10.1016","volume":"129","author":[{"given":"Mark R.","family":"Cullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina R.","family":"Lemeshow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa V.","family":"Bandera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kawachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lunyera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Poss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda M.","family":"Rottas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Schachterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Thadeio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cct.2023.107184_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258858","article-title":"Increasing black, indigenous and people of color participation in clinical trials through community engagement and recruitment goal establishment","volume":"16","author":"Andrasik","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cct.2023.107184_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers","volume":"44","author":"Clark","year":"2019","journal-title":"Curr. Probl. Cardiol."},{"issue":"18","key":"10.1016\/j.cct.2023.107184_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183280","article-title":"Understanding multilevel factors related to Urban Community Trust in Healthcare and Research","volume":"16","author":"Webb Hooper","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cct.2023.107184_bb0020","author":"National Academies of Sciences, Engineering, and Medicine"},{"key":"10.1016\/j.cct.2023.107184_bb0025","first-page":"11","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study","author":"Turner","year":"2022","journal-title":"Lancet. Reg. Health. Am."},{"key":"10.1016\/j.cct.2023.107184_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106421","article-title":"Demographic diversity of participants in Pfizer sponsored clinical trials in the United States","volume":"106","author":"Rottas","year":"2021","journal-title":"Contemp. Clin. Trials."},{"key":"10.1016\/j.cct.2023.107184_bb0035","author":"US Food and Drug Administration (FDA)"},{"key":"10.1016\/j.cct.2023.107184_bb0040","unstructured":"United States Census Bureau, Explore Census Data (2022). https:\/\/data.census.gov\/cedsci\/ (accessed September 29 2022). Table P1. DECENNIAL 2020."},{"key":"10.1016\/j.cct.2023.107184_bb0045","author":"Optum EHR Data"},{"key":"10.1016\/j.cct.2023.107184_bb0050","author":"National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program Data 2022"},{"key":"10.1016\/j.cct.2023.107184_bb0055","unstructured":"Centers for Disease Control and Prevention (CDC). Public Health Surveillence and Data. https:\/\/www.cdc.gov\/surveillance\/index.html. (accessed September 29 2022)."},{"key":"10.1016\/j.cct.2023.107184_bb0060","author":"Flatiron"},{"issue":"6464","key":"10.1016\/j.cct.2023.107184_bb0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.cct.2023.107184_bb0070","article-title":"Disease-specific health disparities: a targeted review focusing on race and ethnicity","volume":"10","author":"Cullen","year":"2022","journal-title":"Healthcare (Basel)."},{"issue":"3","key":"10.1016\/j.cct.2023.107184_bb0075","first-page":"33","article-title":"Applying weighting methodologies to a commercial database to project US census demographic data","volume":"3","author":"Wasser","year":"2015","journal-title":"Am. J. Account. Care."},{"key":"10.1016\/j.cct.2023.107184_bb0080","author":"US Department of Health and Human Services"},{"key":"10.1016\/j.cct.2023.107184_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.699049","article-title":"Poverty, racism, and the public health crisis in America","volume":"9","author":"Beech","year":"2021","journal-title":"Front. Public Health"},{"issue":"10","key":"10.1016\/j.cct.2023.107184_bb0090","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/jwh.2017.6845","article-title":"Racial\/ethnic disparities in diabetes diagnosis and glycemic control among women of reproductive age","volume":"27","author":"Britton","year":"2018","journal-title":"J. Women\u2019s Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.cct.2023.107184_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jamia\/ocab199","article-title":"The quality of social determinants data in the electronic health record: a systematic review","volume":"29","author":"Cook","year":"2021","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"2","key":"10.1016\/j.cct.2023.107184_bb0100","first-page":"177","article-title":"Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies","volume":"18","author":"Clegg","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cct.2023.107184_bb0105","unstructured":"United States Census Bureau: Decennial Census \u2013 U.S. Census Bureau\". Census.gov. Retrieved July 13, 2022, https:\/\/www.census.gov\/programs-surveys\/decennial-census.html (accessed September 29 2022)."},{"key":"10.1016\/j.cct.2023.107184_bb0110","author":"US Office of Management and Budget"},{"key":"10.1016\/j.cct.2023.107184_bb0115","author":"United States Census Bureau"},{"issue":"12","key":"10.1016\/j.cct.2023.107184_bb0120","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1002\/ibd.22944","article-title":"Common NOD2 risk variants in African Americans with Crohn\u2019s disease are due exclusively to recent Caucasian admixture","volume":"18","author":"Adeyanju","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"10.1016\/j.cct.2023.107184_bb0125","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s10620-014-3160-0","article-title":"Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital","volume":"59","author":"Sofia","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.cct.2023.107184_bb0130","first-page":"1219","article-title":"Gaucher disease: a lysosomal neurodegenerative disorder","volume":"19","author":"Huang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cct.2023.107184_bb0135","unstructured":"Statistica. Distribution of coronavirus (COVID-19) cases in the United States as of September 12, 2022, by ethnicity, https:\/\/www.statista.com\/statistics\/1122384\/coronavirus-covid19-cases-by-ethnicity-us\/. (accessed September 29 2022)."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:59:03Z","timestamp":1761555543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714423001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"alternative-id":["S1551714423001076"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2023.107184","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A framework for setting enrollment goals to ensure participant diversity in sponsored clinical trials in the United States","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2023.107184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Pfizer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107184"}}